Near-infrared photoimmunotherapy using antiGD2 antibody for neuroblastoma and osteosarcoma
Introduction: Near-infrared photoimmunotherapy (NIR-PIT) is a novel cancer therapy that specifically targets cancer cells. In NIR-PIT, antibody-photo-absorber-conjugates (APCs), specific for cancer antigens, target cancer cells. APCs that bind to antigens and are irradiated with NIR-light kill targe...
Saved in:
| Main Authors: | Jimei Zhao, Kohei Nakajima, Masahiro Ueki, Yukayo Terashita, Shinsuke Hirabayashi, Yuko Cho, Mikako Ogawa, Atsushi Manabe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | EJC Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772610X25000212 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Near-infrared photoimmunotherapy for osteosarcoma targeting epidermal growth factor receptor
by: Motofumi Suzuki, et al.
Published: (2024-12-01) -
GD2 targeting CAR T cells for neuroblastoma
by: John Anderson, et al.
Published: (2024-12-01) -
Overcoming resistant cancerous tumors through combined photodynamic and immunotherapy (photoimmunotherapy)
by: Glory Kah, et al.
Published: (2025-07-01) -
The yes-associated protein (YAP) is associated with resistance to anti-GD2 immunotherapy in neuroblastoma through downregulation of ST8SIA1
by: Adeiye A. Pilgrim, et al.
Published: (2023-12-01) -
EpCAM-targeted near-infrared photoimmunotherapy (NIR-PIT) for the treatment of breast cancer
by: Aki Furusawa, et al.
Published: (2025-12-01)